DE
Therapeutic Areas
Hybridize Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| HYB_BKV | BK virus infection in transplant patients | Phase 1/2 |
| HYB_JCV | JC virus infection / Progressive Multifocal Leukoencephalopathy (PML) | Pre-clinical |
| Undisclosed PTEC Program(s) | Metabolic disorders (e.g., hyperphosphatemia, hyperuricemia), ADPKD, Ischemia-Reperfusion Injury, Inflammation/Fibrosis | Pre-clinical |